LCN2 and glycogen storage disease VI: Since NGAL still might be a biomarker and predictive factor in the development of inflammatory- and immune infiltration-related diseases, further observations on COVID-19 patients and people after asymptomatic infection are required to accurately determine the etiology, course, and effect of this phenomenon.